May 25, 2017
Therapix Biosciences looks for new CEO
Therapix Biosciences, a specialty clinical stage pharmaceutical company specializing in the development of cannabinoid-based drugs, has announced that the company’s Chief Executive Officer Dr. Elran Haber will step down from his position to pursue other professional opportunities.